Given the pronounced molecular heterogeneity of GBM, the functional output of beclin-1-dependent autophagy and its coupling to apoptosis is likely to differ across clinically relevant tumour states rather than representing a uniform programme. The gene discussed is BECN1; the disease is neoplasm.